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Migraine is 2-3 times more prevalent in women than in
men, with frequent perimenstrual attacks. TRPV1 recep-
tors on sensory nerve endings of the trigeminal track are
important in mediating migraine attacks by releasing the
vasodilator calcitonin gene-related peptide (CGRP). Varia-
tion in estrogen levels during the menstrual cycle may
have an influence on the sensitivity of the TRPV1 receptor
or on the amount of CGRP in perivascular nerve terminals
and hence on CGRP release. Capsaicin, the active ingredi-
ent of hot chili peppers, stimulates the TRPV1 receptor
and causes CGRP-dependent vasodilatation [1]. We set up
a model to study trigeminal CGRP release in humans. We
compared the vasodilator effects of capsaicin application
and electrical stimulation on the forehead skin. Healthy
women, not using hormonal contraceptives (age: 18-45,
n=14), were studied with a Laser Doppler Imager on day
19-21 of their menstrual cycle and on day 1-2 of their
menstruation. A 0.2 mM and a 20 mM capsaicin solution
were applied to the skin. In addition, iontophoresis of
saline was performed as a TRPV1-independent stimulus.
Increases in dermal blood-flow (DBF) were measured.
Blood samples were collected to measure estrogen levels.
We measured higher DBF responses to application of
0.2 mM capsaicin (Max:226±34 a.u.) and 20 mM capsaicin
(Max:507±39 a.u.) during day 1-2 (low estrogen levels:
15±2 pg/ml) of the menstruation, than during day 19-21
(high estrogen levels: 67±9 pg/ml) of the menstrual cycle
(Max:176±34 a.u. and 432±33 a.u. for 0.2 mM and
20 mM, respectively, P<0.05). There was no difference in
DBF responses to electrical stimulation of the forehead
skin, suggesting that the observed changes are related to
the sensitivity of the TRPV1 receptor. Our results indicate
an influence of variation in estrogen levels on trigeminal
CGRP release, with the highest reactivity observed around
the menstruation when estrogen levels are low. This
mechanism may, at least partly, explain the high incidence
of migraine attacks during the perimenstrual period.
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